Zevra Therapeutics EPS Diluted from Accounting Change (Quarterly) Analysis

Zevra Therapeutics, Inc. (ZVRA)

9.03 +0.01 (+0.11%) USD | NASDAQ | Jan 21, 16:00

9.03 0.00 (0.00%) After-Hours: 20:00

View EPS Diluted from Accounting Change (Quarterly) for ZVRA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Accounting Change (Quarterly) Benchmarks

Start Trial

XOMA Royalty Corp.	--
Verastem, Inc.	--
ADMA Biologics, Inc.	--
Akebia Therapeutics, Inc.	--
NovaBay Pharmaceuticals, Inc.	--